Insider · CIK 0001485088
Andrew J. Last
Files at BIO (BIO-RAD LABORATORIES, INC.), IMDX (Oncocyte Corp). First filing Sep 10, 2024, latest Sep 10, 2024.
In brief
Andrew J. Last files SEC Form 4 as director and COO at BIO (BIO-RAD LABORATORIES, INC.), and also at IMDX (Oncocyte Corp). Since Sep 10, 2024, Andrew J. Last has reported 0 open-market buys worth $0 and 1 open-market sell worth $990k, the latest filed on Sep 10, 2024.
A track record needs three past buys with six months of prices behind them; Andrew J. Last has 0, so none is measured yet.
The newest scored trade: sold $990k of BIO on Sep 6, 2024, filed Sep 10, 2024, scored 48 (moderate).
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
BIO: BIO-RAD LABORATORIES, INC.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 48Moderate | BIO-RAD LABORATORIES, INC. | $990k 3,000 shares | -28% | +25% from low-12% from high |
Planned sales
Form 144 notices this insider filed before selling restricted or control stock, newest first.
| Filed | Company | Shares | Value | Sale date | Past 3 months |
|---|---|---|---|---|---|
| Nov 6, 2024 | BIO BIO-RAD LABORATORIES, INC. | 3,000 0.01% of outstanding | $1.1M | Nov 6, 2024 | $1.5M |
| Sep 12, 2024 | BIO BIO-RAD LABORATORIES, INC. | 1,600 0.01% of outstanding | $515k | Sep 12, 2024 | $990k |
| Sep 6, 2024 | BIO BIO-RAD LABORATORIES, INC. | 3,000 0.01% of outstanding | $990k | Sep 6, 2024 | none |
Transactions
Every row this insider has filed, 23 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Jul 1, 2026 | IMDX Oncocyte Corp | FTax withholding Common Stock, no par value | -7,700 | $5.69 | $44k | 58,752 | Jul 6, 2026 |
| Jun 11, 2026 | IMDX Oncocyte Corp | AGrant or award Common Stock, no par value | +26,943 | $0.00 | $0 | 66,452 | Jun 15, 2026 |
| Jul 1, 2025 | IMDX Oncocyte Corp | AGrant or award Common Stock, no par value | +35,000 | $0.00 | $0 | 39,509 | Jul 3, 2025 |
| Sep 6, 2024 | BIO BIO-RAD LABORATORIES, INC. | MOption exercise Bio-Rad A Common Stock | +3,000 | $299.24 | $898k | 10,559 | Sep 10, 2024 |
| Sep 6, 2024 | BIO BIO-RAD LABORATORIES, INC. | SOpen-market sale Bio-Rad A Common Stock | -3,000 | $329.94 | $990k | 7,559 | Sep 10, 2024 |
| Sep 6, 2024 | BIO BIO-RAD LABORATORIES, INC. | MOption exercise Non-Qualified Stock Option (right to buy)derivative | -3,000 | $0.00 | $0 | 0 | Sep 10, 2024 |
| Sep 1, 2024 | BIO BIO-RAD LABORATORIES, INC. | MOption exercise Bio-Rad A Common Stock | +1,252 | $0.00 | $0 | 7,010 | Sep 4, 2024 |
| Sep 1, 2024 | BIO BIO-RAD LABORATORIES, INC. | FTax withholding Bio-Rad A Common Stock | -635 | $337.32 | $214k | 6,375 | Sep 4, 2024 |
| Sep 1, 2024 | BIO BIO-RAD LABORATORIES, INC. | MOption exercise Bio-Rad A Common Stock | +867 | $0.00 | $0 | 7,242 | Sep 4, 2024 |
| Sep 1, 2024 | BIO BIO-RAD LABORATORIES, INC. | FTax withholding Bio-Rad A Common Stock | -440 | $337.32 | $148k | 6,802 | Sep 4, 2024 |
| Sep 1, 2024 | BIO BIO-RAD LABORATORIES, INC. | MOption exercise Bio-Rad A Common Stock | +633 | $0.00 | $0 | 7,435 | Sep 4, 2024 |
| Sep 1, 2024 | BIO BIO-RAD LABORATORIES, INC. | FTax withholding Bio-Rad A Common Stock | -321 | $337.32 | $108k | 7,114 | Sep 4, 2024 |
| Sep 2, 2024 | BIO BIO-RAD LABORATORIES, INC. | MOption exercise Bio-Rad A Common Stock | +903 | $0.00 | $0 | 8,017 | Sep 4, 2024 |
| Sep 2, 2024 | BIO BIO-RAD LABORATORIES, INC. | FTax withholding Bio-Rad A Common Stock | -458 | $337.32 | $154k | 7,559 | Sep 4, 2024 |
| Sep 1, 2024 | BIO BIO-RAD LABORATORIES, INC. | MOption exercise Restricted Stock Unitsderivative | -1,252 | $0.00 | $0 | 3,756 | Sep 4, 2024 |
| Sep 1, 2024 | BIO BIO-RAD LABORATORIES, INC. | MOption exercise Restricted Stock Unitsderivative | -867 | $0.00 | $0 | 1,735 | Sep 4, 2024 |
| Sep 1, 2024 | BIO BIO-RAD LABORATORIES, INC. | MOption exercise Restricted Stock Unitsderivative | -633 | $0.00 | $0 | 633 | Sep 4, 2024 |
| Sep 2, 2024 | BIO BIO-RAD LABORATORIES, INC. | MOption exercise Restricted Stock Unitsderivative | -903 | $0.00 | $0 | 0 | Sep 4, 2024 |
| Jul 1, 2024 | IMDX Oncocyte Corp | AGrant or award Option to Purchase Common Stockderivative | +30,000 | $0.00 | $0 | 30,000 | Jul 3, 2024 |
| Apr 29, 2024 | BIO BIO-RAD LABORATORIES, INC. | MOption exercise Bio-Rad A Common Stock | +1,000 | $0.00 | $0 | 6,077 | Apr 30, 2024 |
| Apr 29, 2024 | BIO BIO-RAD LABORATORIES, INC. | FTax withholding Bio-Rad A Common Stock | -357 | $277.11 | $99k | 5,720 | Apr 30, 2024 |
| Apr 29, 2024 | BIO BIO-RAD LABORATORIES, INC. | MOption exercise Restricted Stock Unitsderivative | -1,000 | $0.00 | $0 | 0 | Apr 30, 2024 |
| Mar 8, 2024 | BIO BIO-RAD LABORATORIES, INC. | AGrant or award Non-Qualified Stock Option (right to buy)derivative | +5,891 | $0.00 | $0 | 5,891 | Mar 12, 2024 |
Questions about Andrew J. Last
Answered from the filings on this page, as of the latest one.
Is Andrew J. Last buying or selling?
Not in the last 12 months. Andrew J. Last's latest open-market trade on SEC Form 4 was sold $990k of BIO on Sep 6, 2024.
How did Andrew J. Last's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Andrew J. Last has 0.
Where does Andrew J. Last file Form 4?
Andrew J. Last has filed Form 4 at BIO (BIO-RAD LABORATORIES, INC.) as EVP, Chief Operating Officer; IMDX (Oncocyte Corp). A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.